Stem Cell Authority, Ltd. (OTCPK: SCAL)
Health Care · Health Care Providers & Services · US
$—
— today · — 1Y
Stem Cell Authority, Ltd. (OTCPK: SCAL) operates in the Health Care Providers & Services industry within the Health Care sector. The company is valued at $2.44M and employs 0 people.
trading between 0.00 and 0.02.
Tweenvest scores Stem Cell Authority, Ltd. across four factors: value 80/100. Its strongest factor is value.
SCAL price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $2.44M
- Revenue (TTM)
- $3.33M
- P/E
- 0.04
- EPS
- 0.01
- Dividend yield
- —
- Beta (5Y)
- 3.01
- 52-week high
- $0.02
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 12.18B
- Employees
- 0
- Next earnings
- —
About Stem Cell Authority, Ltd.
Stem Cell Authority, Ltd. (SCAL) is a technology innovation firm primarily focused on the retrieval and cryogenic storage of stem cells. The company excels at collecting and banking two specific types of stem cells: hematopoietic stem cells, sourced from umbilical cord blood, and "Miracle Mesenchymal" stem cells, derived from the Wharton's jelly found within a newborn's umbilical cord. SCAL provides healthcare professionals involved in childbirth throughout the United States with advanced technology to offer these vital stem cell preservation services to their maternity patients. The company's operations are based in Fairlawn, Ohio.
- ISIN
- US85857C1080
- Listed since
- Mar 17, 2005
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Health Care Providers & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| UnitedHealth Group IncorporatedNYSE: UNH | $350.16B | $394.52 | +1.13% |
| CVS Health CorporationNYSE: CVS | $118.97B | $93.13 | +0.12% |
| McKesson CorporationNYSE: MCK | $100.14B | $859.78 | +0.10% |
| HCA Healthcare, Inc.NYSE: HCA | $92.92B | $433.83 | +1.08% |
| Elevance Health, Inc.NYSE: ELV | $86.86B | $403.81 | +0.82% |
| The Cigna GroupNYSE: CI | $73.33B | $279.57 | +0.74% |
| Cencora, Inc.NYSE: COR | $60.69B | $320.55 | +0.79% |
| Cardinal Health, Inc.NYSE: CAH | $53.38B | $229.00 | -0.22% |
Figures last refreshed Aug 18, 2026.